Investigator Initiated Studies (IIS) are unsolicited research originating from an external researcher, institution, or organization. These studies may be referred to using other names, including Investigator Initiated Trials (IIT), Investigator Sponsored Trials (IST), or another term that references investigator-initiated or investigator-sponsored research.
Alnylam is using SteepRock as an IIS platform, handling IISs from the investigator’s initial request through completion of the study. Note that this portal is not to be used for Grants, Donations, or Charitable Contributions.
Established Areas of Research Interest:
Transthyretin-mediated (TTR) amyloidosis, acute hepatic porphyria (AHP), primary hyperoxaluria (PH), Other
In order to submit a request for consideration, an applicant must meet the following requirements:
Alnylam is committed to supporting the medical and scientific understanding of our therapeutic areas of interest for healthcare professionals.
Alnylam is not obligated to accept any IIS requests, and requestors may not assume a request has been approved until notified. Approved requests are further subject to the execution of an appropriate contract.
Submit a proposal
Submit a research proposal for an Investigator-Initiated Study.
Important note on disclosure: Alnylam is committed to transparency in its interactions with healthcare professionals and healthcare organizations/institutions consistent with applicable laws and/or codes of practice applicable to the pharmaceutical industry.